Keith Katkin, Director at Emergent BioSolutions Inc. (EBS), sold 15,481 shares at $8.28 ($128K) on 2026-04-30, disclosed to the SEC on 2026-05-04.
Scheduled sale ($128k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SNDX | SELL | 2022-10-07 | $1.5M | — | Filing → |
| SNDX | SELL | 2022-10-04 | $176K | — | Filing → |
| UROV | SELL | 2019-12-11 | $1.5M | — | Filing → |